Follow-Up Study of Kidney Cancer Patients
Follow-up of Kidney Cancer Patients From the Central European Multicenter Case-Control Study
2 other identifiers
observational
1,002
2 countries
3
Brief Summary
Background: In Central Europe, mortality rates for kidney cancers are higher and survival rates are lower than in the United States and Western Europe overall. The Central and Eastern European Renal Cancer Case-Control Study (CEERCC), completed in 2002, offers an opportunity to identify determinants that predict 5-year survival among kidney cancer patients. Objectives: To assess disease recurrence and progression among former participants in the CEERCC. To investigate the effect of genetics, lifestyle factors, medical conditions, occupation and diet on the outcome of kidney cancer patients in Europe. Eligibility: Former participants or next-of-kin of former participants in the CEERCC study. Design: Participants or their next-of-kin are interviewed for 60 minutes and are requested permission to collect relevant information from their or their family member s hospital and cancer registry records.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2008
Longer than P75 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2008
CompletedFirst Posted
Study publicly available on registry
April 14, 2008
CompletedStudy Start
First participant enrolled
April 17, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
June 17, 2020
CompletedJune 18, 2020
June 1, 2020
5.1 years
April 11, 2008
June 17, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survival
Cause-specific and overall mortality
Months of cancer-free survival
Study Arms (1)
Renal cancer patients
Renal cancer patients
Eligibility Criteria
Renal cancer patients
You may qualify if:
- To be eligible for this study, patients needed to have participated as a histologically confirmed renal cancer case in the previous case-control study entitled Central European Renal Cancer Case-Control (CEERCC) Study which was completed in 2002.
You may not qualify if:
- Children less than 18 are not eligible to participate in this study because there were no kidney cancer cases observed in the CEERCC Study that were less than 18 years of age.
- American Indian/Alaskan Native, Asian, Black or African American, Hispanic or Latino, and Native Hawaiian or Pacific Islander.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Dept of Cancer Epidemioology Genetics, Brno, CZ
Brno, Czechia
Olomouc University
Olomouc, Czechia
National Institute of Occupational Medicine, Lodz, Poland
Lodz, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mark P Purdue, M.D.
National Cancer Institute (NCI)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 11, 2008
First Posted
April 14, 2008
Study Start
April 17, 2008
Primary Completion
May 31, 2013
Study Completion
June 17, 2020
Last Updated
June 18, 2020
Record last verified: 2020-06